𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Ifosfamide Treatment Of Patients With Soft Tissue Sarcoma: Health Care Utilization And Cost Implications

✍ Scribed by Engel-Nitz, N.M.; Song, R.; Horstman, T.V.

Book ID
122152066
Publisher
John Wiley and Sons
Year
2013
Tongue
English
Weight
71 KB
Volume
16
Category
Article
ISSN
1098-3015

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Treatment of advanced soft tissue sarcom
Treatment of advanced soft tissue sarcomas with ifosfamide and doxorubicin combination chemotherapy
✍ Bari?ta, ?brah??m; Tekuzman, GοΏ½lten; YalοΏ½in, ?uay??b; GοΏ½llοΏ½, ?brah??m; GοΏ½ler, N? πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 101 KB πŸ‘ 2 views

Our objective was to assess the efficacy of a standard dose ifosfamide and doxorubicin containing regimen in the treatment of advanced soft tissue sarcomas. Forty consecutive patients with a median age of 35.5 years were treated. Ifosfamide was administered at a dose of 2.5 g/m 2 /day as 72-hour con

The efficacy of a combination of etoposi
The efficacy of a combination of etoposide, ifosfamide, and cisplatin in the treatment of patients with soft tissue sarcoma
✍ Zs. PΓ‘pai; Gy. Bodoky; J. SzΓ‘ntΓ³; I. Poller; P. RahΓ³ty; S. Eckhardt; I. LΓ‘ng; M. πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 62 KB πŸ‘ 2 views

## BACKGROUND. Successful chemotherapy for patients with soft tissue sarcoma (STS) has been limited by a lack of active drugs. The most effective single agents are doxorubicin, dacarbazine, and, more recently, ifosfamide. Previously the most widely used combination has been CYVADIC (cyclophosphami